Vaccitech plc
VACC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $14,167 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | -$8,388 |
| Gross Profit | $0 | $0 | $0 | $22,555 |
| % Margin | – | – | – | 159.2% |
| R&D Expenses | $5,390 | $7,953 | $8,290 | $6,656 |
| G&A Expenses | $5,165 | $15,384 | $12,639 | $3,443 |
| SG&A Expenses | $5,165 | $15,384 | $12,639 | $3,443 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $4,667 | $0 | $0 | $0 |
| Operating Expenses | $15,222 | $23,337 | $20,929 | $10,099 |
| Operating Income | $156 | $13 | $329 | $65,102 |
| % Margin | – | – | – | 459.5% |
| Other Income/Exp. Net | -$14,798 | -$21,164 | -$20,009 | $0 |
| Pre-Tax Income | -$14,642 | -$21,151 | -$19,680 | -$2,815 |
| Tax Expense | -$76 | -$27 | -$32 | $2,102 |
| Net Income | -$14,566 | -$21,124 | -$19,648 | -$4,977 |
| % Margin | – | – | – | -35.1% |
| EPS | -0.36 | -0.52 | -0.49 | -0.08 |
| % Growth | 30.8% | -6.1% | -512.5% | – |
| EPS Diluted | -0.36 | -0.52 | -0.49 | -0.08 |
| Weighted Avg Shares Out | 40,661 | 40,344 | 40,265 | 39,348 |
| Weighted Avg Shares Out Dil | 40,661 | 40,344 | 40,265 | 39,348 |
| Supplemental Information | – | – | – | – |
| Interest Income | $472 | $523 | $556 | $372 |
| Interest Expense | $13 | $12 | $13 | -$74 |
| Depreciation & Amortization | $901 | $0 | $0 | -$5,518 |
| EBITDA | -$13,728 | $13 | $329 | -$8,467 |
| % Margin | – | – | – | -59.8% |